HOW DIGITALIZATION CAN BE UTILIZED FOR BETTER MARKETING & SALES IN PHARMACEUTICALS
Proteus Discover is the world’s first digital medicine approved by FDA in 2012. It is designed for health organizations searching for efficient, patient centric approach to measure, manage and improve health of patients. It consists of an ingestible sensor the size of a grain of sand, a small wearable sensor patch, an application on a mobile device and a provider portal. The patient activates Proteus Discover by taking medication with an ingestible sensor. Once the ingestible sensor reaches the stomach, it transmits a signal to the patch worn on the torso. A digital record is sent to the patient’s mobile device and then to the Proteus cloud where with the patient’s permission, healthcare providers and caregivers can access it via their portal. The patch also measures and shares patient activity and rest. Recently, in May 2017, Otsuka Pharmaceutical and Proteus Digital Health® has resubmitted the New Drug Application (NDA) with FDA for the drug-device combination product of ABILIFY® (aripiprazole) embedded with a Proteus ingestible sensor in a single tablet.
In 2015, Verily (formerly Google Life Sciences) filed a patent for a needle free blood draw device at US Patent and Trademark Office. This device designed for people who are frequently needed to test their blood. Google is already in collaboration with Novartis, working on smart lenses that will analyze tear to sense blood glucose level and provide real time data. On one step ahead, Google is also developing cloud-connected sensor which can monitor blood sugar.
Don’t you think such new innovations can change the healthcare revenue system ? Write your feedback!
NOW YOU CAN ALSO PUBLISH YOUR ARTICLE ONLINE.
SUBMIT YOUR ARTICLE/PROJECT AT firstname.lastname@example.org
FIND OUT MORE ARTICLES AT OUR DATABASE